BioCentury | Jan 14, 2021
Finance

With €127M series B, cancer vaccine developer IO Biotech raises second-largest European venture round in the past year

...Sciences, Soleus Capital, Eir Ventures and Serrado Capital. Existing investors Novo Seeds, Lundbeckfonden Emerge and Sunstone Life Science Ventures...
...Myers Squibb Co. Novo Holdings A/S Vivo Capital Kurma Partners Avoro Capital Advisors RA Capital Management Samsara BioCapital Idinvest Partners Soleus Capital Eir Ventures Lundbeckfond Emerge Sunstone Life Science Ventures Cancer Non-small...
BioCentury | Dec 17, 2020
Finance

Dec. 16 Quick Takes: Neurogene raises $115M while BioAtla sees first-day pop; plus fundings for Atsena, MinervaX, Vivace, Arvinas

...Ventures, Wellington Partners, Adjuvant Capital and Industrifonden joined prior backers Novo Holdings REPAIR Impact Fund, Sunstone Life Science Ventures...
BioCentury | Nov 14, 2020
Product Development

Complete response for Sanofi’s rare anemia candidate; plus Sumitovant-Urovant, C4-Roche, IN8bio and Synendos

...Therapeutics raised CHF20 million ($21.9 million) in a series A co-led by Kurma Partners and Sunstone Life Science Ventures...
BioCentury | Oct 1, 2019
Finance

STING start-up STipe first to emerge from Novo incubator

STipe, the first company out of Novo’s BioInnovation Initiative, raised €20 million ($21.9 million) in a series A round to develop technology designed to improve the therapeutic window of STING modulators in the clinic. Novo...
BioCentury | Jul 19, 2019
Financial News

July 19 Financial Quick Takes: Amarin raises cash ahead of Vascepa PDUFA date, plus Atara, Sunstone and Forendo

...off $0.27 to $15.01 in late afternoon trading Friday. Sunstone joins endometriosis company Forendo's syndicate Sunstone Life Science Ventures...
BioCentury | May 26, 2008
Finance

Midlife crisis

...a year ago taking with it the cream of the original portfolio. Sunstone now manages Sunstone Life Science Ventures...
Items per page:
1 - 6 of 6
BioCentury | Jan 14, 2021
Finance

With €127M series B, cancer vaccine developer IO Biotech raises second-largest European venture round in the past year

...Sciences, Soleus Capital, Eir Ventures and Serrado Capital. Existing investors Novo Seeds, Lundbeckfonden Emerge and Sunstone Life Science Ventures...
...Myers Squibb Co. Novo Holdings A/S Vivo Capital Kurma Partners Avoro Capital Advisors RA Capital Management Samsara BioCapital Idinvest Partners Soleus Capital Eir Ventures Lundbeckfond Emerge Sunstone Life Science Ventures Cancer Non-small...
BioCentury | Dec 17, 2020
Finance

Dec. 16 Quick Takes: Neurogene raises $115M while BioAtla sees first-day pop; plus fundings for Atsena, MinervaX, Vivace, Arvinas

...Ventures, Wellington Partners, Adjuvant Capital and Industrifonden joined prior backers Novo Holdings REPAIR Impact Fund, Sunstone Life Science Ventures...
BioCentury | Nov 14, 2020
Product Development

Complete response for Sanofi’s rare anemia candidate; plus Sumitovant-Urovant, C4-Roche, IN8bio and Synendos

...Therapeutics raised CHF20 million ($21.9 million) in a series A co-led by Kurma Partners and Sunstone Life Science Ventures...
BioCentury | Oct 1, 2019
Finance

STING start-up STipe first to emerge from Novo incubator

STipe, the first company out of Novo’s BioInnovation Initiative, raised €20 million ($21.9 million) in a series A round to develop technology designed to improve the therapeutic window of STING modulators in the clinic. Novo...
BioCentury | Jul 19, 2019
Financial News

July 19 Financial Quick Takes: Amarin raises cash ahead of Vascepa PDUFA date, plus Atara, Sunstone and Forendo

...off $0.27 to $15.01 in late afternoon trading Friday. Sunstone joins endometriosis company Forendo's syndicate Sunstone Life Science Ventures...
BioCentury | May 26, 2008
Finance

Midlife crisis

...a year ago taking with it the cream of the original portfolio. Sunstone now manages Sunstone Life Science Ventures...
Items per page:
1 - 6 of 6